These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29986353)

  • 1. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
    Lazarus JV; Safreed-Harmon K; Thursz MR; Dillon JF; El-Sayed MH; Elsharkawy AM; Hatzakis A; Jadoul M; Prestileo T; Razavi H; Rockstroh JK; Wiktor SZ; Colombo M
    Semin Liver Dis; 2018 Aug; 38(3):181-192. PubMed ID: 29986353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How would China achieve WHO's target of eliminating HCV by 2030?
    Li M; Zhuang H; Wei L
    Expert Rev Anti Infect Ther; 2019 Oct; 17(10):763-773. PubMed ID: 31578079
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating viral hepatitis C in Belgium: the micro-elimination approach.
    Busschots D; Toghanian S; Bielen R; Salomonsson S; Koc ÖM; Hendrickx G; Jadoul M; Nevens F; Sokal E; Brixko C; Peerlinck K; Apers L; Robaeys G; Lazarus JV
    BMC Infect Dis; 2020 Feb; 20(1):181. PubMed ID: 32106819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Securing sustainable funding for viral hepatitis elimination plans.
    Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
    Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of hepatitis C in Europe: can WHO targets be achieved?
    Matičič M; Lombardi A; Mondelli MU; Colombo M;
    Clin Microbiol Infect; 2020 Jul; 26(7):818-823. PubMed ID: 31978546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C: Is eradication possible?
    Lombardi A; Mondelli MU;
    Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies.
    Mousavi S; Alavi M; Delavari A; Poustchi H; Mohammadi Z; Malekzadeh R
    J Viral Hepat; 2024 Sep; 31(9):565-572. PubMed ID: 38831601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring hepatitis C virus elimination as a public health threat: Beyond global targets.
    van Santen DK; Sacks-Davis R; Doyle JS; Scott N; Prins M; Hellard M
    J Viral Hepat; 2020 Aug; 27(8):770-773. PubMed ID: 32187431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global elimination of hepatitis C?
    Sonderup MW
    S Afr Med J; 2018 Aug; 108(8b):31-34. PubMed ID: 30182910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovations in Hepatitis C Screening and Treatment.
    Patel AA; Bui A; Prohl E; Bhattacharya D; Wang S; Branch AD; Perumalswami PV
    Hepatol Commun; 2021 Mar; 5(3):371-386. PubMed ID: 33681673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic.
    Bajis S; Applegate TL; Grebely J; Matthews GV; Dore GJ
    J Infect Dis; 2020 Nov; 222(Suppl 9):S758-S772. PubMed ID: 33245354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliminating hepatitis C.
    Burki T
    Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
    Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements.
    Kondili LA; Craxì A; Aghemo A
    Liver Int; 2021 Apr; 41(4):649-655. PubMed ID: 33486885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges.
    Behzadifar M; Azari S; Gorji HA; Martini M; Bragazzi NL
    J Prev Med Hyg; 2020 Mar; 61(1):E109-E118. PubMed ID: 32490276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global hepatitis C elimination: an investment framework.
    Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized US Efforts to Eliminate Hepatitis C.
    Gaudino A; Gay B; Garmon C; Selick M; Vreeland R; Burk K; Huriaux E; Facente SN; Luetkemeyer A; Waters P; Graham CS
    Infect Dis Clin North Am; 2018 Jun; 32(2):293-311. PubMed ID: 29778257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C treatment as prevention: evidence, feasibility, and challenges.
    Hajarizadeh B; Grebely J; Martinello M; Matthews GV; Lloyd AR; Dore GJ
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):317-327. PubMed ID: 28404202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.